Biorasis
Mansfield Center
About Biorasis
BIORASIS was established in Dec. 2007 with an initial goal to commercialize UCONN’s and OSCI’s wireless, needle-implantable, miniaturized (0.5 x 0.5 x 5 mm) sensor platform for real time, continuous glucose monitoring. In addition to glucose monitoring Biorasis is working towards outfitting its sensor platform to monitor other bio-analytes in the body that are important in other disorders such as cardiovascular, cancer, liver, kidney abnormalities, stroke and epilepsy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $3.8M
- Last round: Grant (Dec 2018)
- Website: bio-orasis.com
- Phone: 860-486-9188
Industries & Categories
Biotechnology, Health Care, Internet, Wireless
Social Profiles
Canonical: https://fsome.com/organization/biorasis-91548 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.